申请人:CZECHTIZKY Werngard
公开号:US20130065859A1
公开(公告)日:2013-03-14
The present invention relates to substituted 2-(chroman-6-yloxy)-thiazoles of the formula I,
in which Ar, R2, R3 and R4 are as defined in the claims. The compounds of the formula I are inhibitors of the sodium-calcium exchanger (NCX), especially of the sodium-calcium exchanger of subtype 1 (NCX1), and are suitable for the treatment of diverse disorders in which intracellular calcium homeostasis is disturbed, such as arrhythmias, heart failure and stroke. The invention furthermore relates to processes for the preparation of the compounds of the formula I, their use as pharmaceuticals, and pharmaceutical compositions comprising them.
本发明涉及式I的取代2-(色甘醇-6-氧基)-噻唑衍生物,其中Ar、R2、R3和R4如权利要求中所定义。式I的化合物是钠-钙交换蛋白(NCX)的抑制剂,特别是亚型1的钠-钙交换蛋白(NCX1),适用于处理细胞内钙离子稳态受扰的各种疾病,如心律失常、心力衰竭和中风。本发明还涉及制备式I的化合物的方法,它们作为药物的用途,以及包含它们的药物组合物。